全文获取类型
收费全文 | 291篇 |
免费 | 22篇 |
国内免费 | 27篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 20篇 |
妇产科学 | 3篇 |
基础医学 | 37篇 |
口腔科学 | 19篇 |
临床医学 | 52篇 |
内科学 | 91篇 |
皮肤病学 | 8篇 |
神经病学 | 3篇 |
特种医学 | 25篇 |
外科学 | 21篇 |
综合类 | 18篇 |
预防医学 | 12篇 |
药学 | 14篇 |
中国医学 | 1篇 |
肿瘤学 | 15篇 |
出版年
2022年 | 2篇 |
2021年 | 1篇 |
2020年 | 1篇 |
2019年 | 4篇 |
2018年 | 6篇 |
2017年 | 8篇 |
2016年 | 7篇 |
2015年 | 5篇 |
2014年 | 8篇 |
2013年 | 13篇 |
2012年 | 6篇 |
2011年 | 6篇 |
2010年 | 12篇 |
2009年 | 12篇 |
2008年 | 8篇 |
2007年 | 16篇 |
2006年 | 10篇 |
2005年 | 18篇 |
2004年 | 8篇 |
2003年 | 2篇 |
2002年 | 8篇 |
2001年 | 10篇 |
2000年 | 5篇 |
1999年 | 9篇 |
1998年 | 23篇 |
1997年 | 19篇 |
1996年 | 17篇 |
1995年 | 14篇 |
1994年 | 14篇 |
1993年 | 3篇 |
1992年 | 3篇 |
1991年 | 4篇 |
1990年 | 3篇 |
1989年 | 7篇 |
1988年 | 5篇 |
1987年 | 6篇 |
1986年 | 11篇 |
1985年 | 4篇 |
1982年 | 2篇 |
1981年 | 2篇 |
1980年 | 1篇 |
1979年 | 1篇 |
1978年 | 3篇 |
1977年 | 4篇 |
1976年 | 5篇 |
1975年 | 3篇 |
1943年 | 1篇 |
排序方式: 共有340条查询结果,搜索用时 15 毫秒
101.
Inhaled dry powder mannitol in children with cystic fibrosis: A randomised efficacy and safety trial
K De Boeck E Haarman J Hull LC Lands A Moeller A Munck J Riethmüller H Tiddens S Volpi J Leadbetter B Charlton A Malfroot 《Journal of cystic fibrosis》2017,16(3):380-387
Introduction
Inhaled mannitol has beneficial effects on lung function, mucociliary clearance, quality of life and sputum properties. This trial examined the efficacy of inhaled mannitol in children with cystic fibrosis (CF).Methods
The efficacy of inhaled mannitol in children with CF aged 6–17 years was assessed in a phase 2, randomised, placebo-controlled crossover study. Subjects were randomly assigned to mannitol 400 mg every 12 h or matching placebo for 8 weeks, followed by an 8 week washout and an 8 week period with the alternate treatment. The primary endpoint was the absolute change from baseline in ppFEV1 (percent predicted FEV1).Results
A total of 92 subjects were studied, with a mean age of 12 years and mean baseline ppFEV1 of 72.2%. During mannitol treatment ppFEV1 was 3.42% (p = 0.004) higher compared to placebo or a 4.97% (p = 0.005) relative difference; relative change from baseline FEF25-75 was 10.52% (p = 0.013). During mannitol treatment, acute post-treatment sputum weight was higher (p = 0.012). In pre-specified subgroups (rhDNase use, age, and disease severity), the treatment differences consistently favoured mannitol. The most common AEs were cough and pulmonary exacerbations. Pulmonary exacerbation AEs were approximately 30% lower in the mannitol group.Conclusions
In children with CF, inhaled mannitol was associated with significant improvements in lung function and sputum weight, irrespective of rhDNase use, age or disease severity. Inhaled mannitol was well tolerated and was associated with a reduced incidence of pulmonary exacerbation AEs. (Clinical Trials.Gov: NCT 01883531) 相似文献102.
103.
Establishment of two new myeloma cell lines from bilateral pleural effusions: evidence for sequential in vivo clonal change 总被引:3,自引:0,他引:3
Durie BG; Vela E; Baum V; Leibovitz A; Payne CM; Richter LC; Grogan TM; Trent JM 《Blood》1985,66(3):548-555
Two new human myeloma cell lines have been established from a 36-year- old woman with refractory IgG kappa multiple myeloma in whom bilateral malignant pleural effusions developed. The malignant plasma cells from each effusion were set up in a liquid culture using an L-15 medium containing catalase, glutathione, selenous acid, ascorbic acid, insulin, transferrin, additional glutamine hydrocortisone, and 2- mercaptoethanol and designated as M-3 medium. Two IgG kappa cell lines, LB -831 and LB-832, were established and proved to be Epstein-Barr virus negative using the internal repeat sequence DNA probe. Characteristic plasma cell morphology was evident by light and electron microscopy. Immunotyping revealed an IgG kappa , B1+, B2-, Ia (HLA- DR)+, CALLA+ phenotype for each cell line as well as for the original pleural fluid and bone marrow myeloma cells. The supernatants also contained IgG kappa, beta 2 microglobulin, and large amounts of osteoclast-activating factor (indicating bone-resorbing activity). Cytogenetic analysis of the LB-831 cell line revealed a nearly triploid highly abnormal karyotype with numerous clonal chromosomal abnormalities involving chromosomes 1, 3, 5, 7, 13, and 15; several structurally abnormal marker chromosomes; and a putative homogeneously staining region on chromosome 7p at band p22. Analysis of the LB-832 cell line revealed several additional clonal abnormalities. These additional cytogenetic changes suggest that in vivo sequential clonal evolution occurred in this patient. Therefore, two new but related cell lines have been established, which should prove useful for further biological studies. 相似文献
104.
Background
Several humoral immune factors are responsible for a successful pregnancy. There are a few studies, which demonstrate the role of antipaternal cytotoxic antibodies (APCA) and mixed lymphocyte reaction blocking factor (MLR-Bf) in the maintenance of pregnancy. However, these factors have not been studied in women with history of recurrent spontaneous abortion (RSA). We designed this study to review the role of APCA and MLR-Bf in normal pregnancy as well as in women with a history of RSA. 相似文献105.
李继承 《中国医学科学院学报》2000,22(2):159-164
目的 研究Down综合征动物模型常染色体16三体胎鼠及其正常同窝鼠肠神经系发育状况。方法 (1)将NMR-1雌鼠与携带有两个Robertsonian(Rb)易位(11,16),Rb(16,17)8Lubt^WLub3雄鼠进行交配,繁殖常染色体16三体胎鼠。(2)采用细胞遗传学分析,以检出两条Rb染色体和41条染色体者定为常染色体16三体胎鼠。(3)采用高度特异的神经标记物蛋白基因产物9.5抗体进行 相似文献
106.
JC?CohenEmail author M?Gyansa-Lutterodt K?Torpey LC?Esmail G?Kurokawa 《Globalization and health》2005,1(1):17
There are acute disparities in pharmaceutical access between developing and industrialized countries. Developing countries
make up approximately 80% of the world's population but only represent approximately 20% of global pharmaceutical consumption.
Among the many barriers to drug access are the potential consequences of the Trade Related Aspects of Intellectual Property
Rights (TRIPS) Agreement. Many developing countries have recently modified their patent laws to conform to the TRIPS standards,
given the 2005 deadline for developing countries. Safeguards to protect public health have been incorporated into the TRIPS
Agreement; however, in practice governments may be reluctant to exercise such rights given concern about the international
trade and political ramifications. The Doha Declaration and the recent Decision on the Implementation of Paragraph 6 of the
Doha Declaration on the TRIPS Agreement and Public Health may provide more freedom for developing countries in using these
safeguards. This paper focuses on Ghana, a developing country that recently changed its patent laws to conform to TRIPS standards.
We examine Ghana's patent law changes in the context of the Doha Declaration and assess their meaning for access to drugs
of its population. We discuss new and existing barriers, as well as possible solutions, to provide policy-makers with lessons
learned from the Ghanaian experience. 相似文献
107.
108.
Roessler E; Belloni E; Gaudenz K; Vargas F; Scherer SW; Tsui LC; Muenke M 《Human molecular genetics》1997,6(11):1847-1853
Holoprosencephaly (HPE) is the most common brain anomaly in humans,
involving abnormal formation and septation of the developing central
nervous system. Among the heterogeneous causes of HPE, mutations in the
Sonic Hedgehog (SHH) gene have been shown to result in an autosomal
dominant form of the disorder. Here we describe a total of five different
mutations in the processing domain encoded by exon 3 of SHH in familial and
sporadic HPE. This is the first instance in humans where SHH mutations in
the domain responsible for autocatalytic cleavage and cholesterol
modification of the N-terminal signaling domain of the protein have been
observed.
相似文献
109.
目的:探索构建组织工程化仿生骨种植体的方法流程,并制备成骨细胞-可吸收载体种植体样品,同时尝试建立组织工程化非承载骨种植体的评价方法。方法:实验于2001-05/2005-12分别在天津市口腔医院组织工程实验室和天津大学材料学院高分子材料研究所完成。①通过相分离技术制备壳聚糖/明胶三维网络多孔支架,在支架材料表面原位沉积纳米级的羟基磷灰石晶体,构筑纳米羟基磷灰石/壳聚糖/明胶仿生骨组织工程支架材料,并进行表征和性能检测。②用酶消化法和条件培养法分离、诱导培养中国小型猪成骨细胞作为组织工程种子细胞。③用静态复合共培养法体外构建2种骨组织工程种植体样品:成骨细胞-纳米羟基磷灰石/壳聚糖/明胶仿生骨种植体,成骨细胞-纳米羟基磷灰石/胶原种植体。④采用扫描电镜、透射电镜、FDA荧光、LDH、MTT等定期观测仿生骨样品中细胞形态、细胞增殖速率、碱性磷酸酶活性、矿化结节形成等指标,以比较样品的细胞增殖活性和成骨活性。结果:①成功构筑了具有良好的生物相容性和力学相容性的纳米羟基磷灰石/壳聚糖/明胶,这种材料具有适于细胞黏附与生长的(90±1)%的孔隙率,孔径为100 ̄300μm的微孔结构,且原位沉积的纳米羟基磷灰石晶体的粒径为50nm左右,接近与天然骨的组成。②自中国小型猪腿骨成功分离培养了成骨细胞,并在诱导培养条件下,表现出很强的增殖活力和成骨活性,适合作为实验用骨组织工程的种子细胞。③成功构建了两种成骨细胞-可吸收载体种植体样品:经检验仿生构建的小型猪成骨细胞-纳米羟基磷灰石/壳聚糖/明胶种植体具有细胞亲和性和体外成骨活性。结论:①在体外成功仿生构建了结构与活性接近天然骨的骨组织工程种植体--纳米羟基磷灰石/壳聚糖/明胶种植体。②初步建立了仿生组织工程化非承载骨种植体的评价方法,为其进一步用于体内修复颅颌骨组织损伤的深化研究提供了实验数据和科学依据。 相似文献
110.